Advanced Cell Technology, Inc. Applauds California Supreme Court's Decision Regarding $3 Billion Stem Cell Research Program, Proposition 71.

"Request Denied" Ruling Clears Final Hurdle to State Funding of Research

ALAMEDA, Calif. -- Advanced Cell Technology, Inc. (OTCBB: ACTC) applauds the $3 Billion Stem Cell Research Program, Proposition 71, upheld yesterday by the California Supreme Court. In a "request denied" ruling, the California Supreme Court declined to review the challenge brought forward by opponents of the measure.

The challenge to Proposition 71 was not upheld by the state appellate court in February of this year. It was then brought before the state Supreme Court, which yesterday declined to consider the petitions.

William M. Caldwell, IV, Chairman and Chief Executive Officer of Advanced Cell Technology, commented, "California voters made their intentions clear three years ago by voting for Proposition 71: they want California to be in the forefront of supporting stem cell research, which has the potential to cure a host of diseases and degenerative conditions. Yesterday, at long last, the final roadblock to implementing the will of the people of the Golden State has been cleared. Yesterday's decision means that California is now on its way to becoming the world's single largest backer of stem cell research. Indeed, the state could start issuing bonds in the very near future."

Mr. Caldwell continued, "Advanced Cell Technology is fortunate to be headquartered in the great state of California as we work to accelerate the transition of our stem cell therapies to the bedside."

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.